Sai Life Sciences Ltd
Ticker: SAILIFE
Decent
72/100
☆ Add to Watchlist
Investing Reference
Price
858.55
Market Cap
17983.21
Debt/Equity
0.1656
ROE %
10.964
PB
8.4493
Promoter %
35.146
Pledge %
0.003
1Y Rev Growth %
15.866
5Y Rev Growth %
18.424
NP Margin %
9.826
NP Margin 5Y Avg %
4.925
Trading Reference
1M Return %
-2.576
6M Return %
11.348
1Y Return %
12.280
% Away 52W High
9.836
% Away 52W Low
34.971
Daily Volume
425620
Investment Verdict
Risky
Score 52/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 38/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Sai Life Sciences Ltd is currently trading near a key support level, with the 50-day EMA showing a bullish crossover with the 200-day EMA. Volume has been increasing, indicating strong buying interest. If the stock breaks above the resistance level, it could see significant upside in the medium term. However, if it falls below the support level, there could be a notable downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Grindwell Norton Ltd
Grindwell Norton Ltd shows a decent investment potential with consistent growth and profitability metrics, though some execution risks exist.
View details
G
Gujarat Mineral Development Corporation Ltd
The stock shows decent fundamentals but lacks strong growth drivers and competitive advantages.
View details
C
Century Plyboards (India) Ltd
Century Plyboards shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious and monitor market conditions closely.
View details
C
Capri Global Capital Ltd
Capri Global Capital Ltd shows potential but faces significant risks that may affect its growth and stability.
View details
J
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
A
Aditya Birla Lifestyle Brands Ltd
Aditya Birla Lifestyle Brands Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious and consider market conditions.
View details
G
Gabriel India Ltd
Gabriel India Ltd shows potential in a transitioning sector, but faces challenges in growth consistency and profitability metrics.
View details
D
Deepak Fertilisers and Petrochemicals Corp Ltd
The company shows potential for growth but faces several challenges that could impact its performance.
View details
V
Vinati Organics Ltd
Vinati Organics Ltd shows potential for growth with solid fundamentals, but investors should be cautious of execution risks and market volatility.
View details
V
Vedant Fashions Ltd
Vedant Fashions Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
V
Ventive Hospitality Ltd
Ventive Hospitality Ltd shows potential but faces significant challenges in profitability and market conditions, making it a risky investment.
View details
G
Gujarat State Petronet Ltd
Gujarat State Petronet Ltd shows decent potential with consistent growth and profitability metrics, but valuation concerns and execution risks should be monitored.
View details
U
UTI Asset Management Company Ltd
UTI Asset Management Company Ltd shows potential for growth, but faces challenges in profitability and competition.
View details
J
JM Financial Ltd
JM Financial Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
W
Whirlpool of India Ltd
Whirlpool of India Ltd shows decent potential, but faces challenges in profitability and execution risks.
View details
C
Concord Biotech Ltd
Concord Biotech Ltd shows potential for growth but faces challenges in valuation and execution risks.
View details
Business Overview
Sai Life Sciences Ltd is a prominent Indian contract research and manufacturing organization (CRMO) specializing in the biopharmaceutical sector. Catering to global pharmaceutical companies, it offers comprehensive solutions from drug discovery to commercial manufacturing. With a commitment to quality and innovation, Sai Life Sciences plays a crucial role in accelerating drug development processes. Its strategic partnerships and state-of-the-art facilities ensure reliability and efficiency, making it a preferred choice for clients seeking to bring life-saving therapies to market.
- Leading CRMO in India
- Focus on biopharmaceuticals
- Comprehensive drug development solutions
- Strong global partnerships
- Commitment to quality and innovation
Investment Thesis
Sai Life Sciences Ltd stands out as a compelling investment due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. With a solid foundation and a promising growth trajectory, it presents a unique opportunity for investors seeking long-term gains.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services, tapping into emerging trends.
- Attractive valuation metrics compared to industry peers, offering a margin of safety.
- Focus on innovation and expansion positions the company favorably in the market.
- Commitment to sustainability and quality strengthens brand reputation.
Opportunity vs Risk
Opportunities
- Strong growth in biotech sector
- Increasing demand for contract research
- Expansion into international markets
- Innovative product pipeline
- Strategic partnerships with pharma companies
Risks ⚠️
- Regulatory challenges in drug approval
- High competition in biotech space
- Dependence on key clients
- Market volatility affecting stock price
- Economic downturn impacting funding
Peer Perspective
Sai Life Sciences Ltd trades at a discount to peers like Laurus Labs and Divi's Laboratories, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating in its valuation.
Future Outlook
Sai Life Sciences Ltd is well-positioned for growth in the biotech sector, provided it maintains strong execution and cost control. Continued innovation and strategic partnerships could enhance its competitive advantage in the coming years.
AI FAQs for Retail Users
- Q: What does Sai Life Sciences Ltd do?A: Sai Life Sciences Ltd is a contract development and manufacturing organization focused on pharmaceuticals.
- Q: Is Sai Life Sciences Ltd listed on the stock exchange?A: Yes, Sai Life Sciences Ltd is listed on the National Stock Exchange of India.
- Q: What factors can affect Sai Life Sciences Ltd's stock price?A: Factors include market conditions, company performance, and industry trends.
- Q: How can I invest in Sai Life Sciences Ltd?A: You can invest through a brokerage account that allows trading on the stock exchange.
- Q: What is the risk of investing in Sai Life Sciences Ltd?A: Like all stocks, investing carries risks, including market volatility and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Sai Life Sciences Ltd • Updated: 2025-09-18 00:50:04
-
10BusinessHighThe company operates in the pharmaceutical sector, which is considered future-ready due to increasing global demand for healthcare solutions.
-
10GrowthHighConsistent revenue growth over the past few years, but profit growth has been somewhat volatile.
-
10ProfitabilityHighROE and ROCE are decent, but OCF has shown fluctuations compared to net profit.
-
8ValuationHighValuation metrics like P/E and P/B are slightly above industry averages, indicating potential overvaluation.
-
7BalanceHighModerate debt levels with reasonable liquidity, but reserves could be stronger.
-
6GovernanceGoodPromoter holding is stable, but there are some concerns regarding pledging.
-
9DriversHighStrong growth drivers in contract research and manufacturing, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is mixed with moderate liquidity and some recent price volatility.
Final Score & Verdict
Score 72 / 100
• Decent
Sai Life Sciences Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 80/100
- Profitability: 70/100
- Governance: 65/100
- Market Confidence: 72/100